The company observed reduced staff expenses and regulatory contributions, as well as a significant 14% quarter-on-quarter (QoQ) decrease.
The cosmetics company reported a profit of ₹5.85 Crore in the same quarter previous year. On a quarterly basis, net profit increased 4.1%.
The authorised ANDA is a therapeutic equivalent of the reference-listed drug (RLD), Corlanor tablets, in the same 5 mg and 7.5 mg dosages.
EBITDA increased by 3% to ₹47.8 Crore in the second quarter of this fiscal year, up from ₹46.4 Crore in the same period last year.
According to the Chief Minister, the company will invest ₹130 Crore per CBG facility, creating an estimated 2.5 lakh jobs.
The new factory will use a proprietary technology that combines carbon dioxide extracted from energy generation emissions.
On November 12, the indices shred earlier gains and closed negative amid selling across sectors.
Here are some of the stocks that may see significant price movement today: Tata Chemicals, GSFC, Varun Beverages, etc.
The revenue for the September quarter rose by 33% to ₹1,371 crore from ₹1,031 crore in the corresponding period last year.
NTPC issued a Limited Notice to Proceed (LNTP) to BHEL, allowing the company to begin the initial engineering phases of the main plant package.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.